Jentadueto

Quote

Anonymous

Guest
hahahahahahahahahahhha.....great name. I so feel for the ones that have to try and sell this dog. What idiot in this dying organization came up with the worst name ever for a drug?
 
























Anonymous said:
Skippy what are you some kind of idiot? The FDA doesn't decide the brand name of a drug you putz.
Click to expand...

100% they do. FDA has final say. And the FDA can change it if it is too similar sounding to another drug and it is being confused. I'll give you proof. Takeda had a PPI called Kapidex. It was being confused with Casodex.

http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm203096.htm

So suck on that you arrogant know-it-all. I feel bad for your coworkers, having to deal with what you are called in the industry, " a bad hire."
 






Anonymous said:
100% they do. FDA has final say. And the FDA can change it if it is too similar sounding to another drug and it is being confused. I'll give you proof. Takeda had a PPI called Kapidex. It was being confused with Casodex.

http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm203096.htm

So suck on that you arrogant know-it-all. I feel bad for your coworkers, having to deal with what you are called in the industry, " a bad hire."
Click to expand...

The sponsor of the filing proposes several names to the FDA usually prior to filing, they give non-binding advice to the sponsor on whether there are issues with the name/names. The sponsor then files the NDA or ANDA with their chosen brand name.

The FDA could still then reject the name on safety grounds (as with the example above) or because it may be seen as inappropriate (claims of superiority or off label use, etc.) and the sponsor has to propose an alternative before the drug is approved.

So this name was proposed by the sponsor and not rejected by the FDA. The sponsor's preferred name may not have been accepted in the screen and this name was a reserve. Or the name tested fantastically well. I suspect the former.... But who knows when you put your faith in market research...
 






Anonymous said:
100% they do. FDA has final say. And the FDA can change it if it is too similar sounding to another drug and it is being confused. I'll give you proof. Takeda had a PPI called Kapidex. It was being confused with Casodex.

http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm203096.htm

So suck on that you arrogant know-it-all. I feel bad for your coworkers, having to deal with what you are called in the industry, " a bad hire."
Click to expand...

I am not the "arrogant know it all" from the previous post that you refer to but to say that the FDA picks the brand name is inaccurate. Theyt will give a thumbs up or down to the brand name proposed by the company but they don't "pick the name".
Get ot right my friend and don't be so sensitive when you are proven wrong.
 






Anonymous said:
I am not the "arrogant know it all" from the previous post that you refer to but to say that the FDA picks the brand name is inaccurate. Theyt will give a thumbs up or down to the brand name proposed by the company but they don't "pick the name".
Get ot right my friend and don't be so sensitive when you are proven wrong.
Click to expand...

So then who has the final say? THE FDA!!!!!!!!!!!!!!!!
 






Lilly used to do the best job in the industry when it came to product names. Look at all of the old antibiotics that were big hits. Keflex, Kefzol, Moxam, Mandol. The ideal name is 5 or 6 letters, 2 syllables.
 












Anonymous said:
Lilly used to do the best job in the industry when it came to product names. Look at all of the old antibiotics that were big hits. Keflex, Kefzol, Moxam, Mandol. The ideal name is 5 or 6 letters, 2 syllables.
Click to expand...

Absolutely correct! Just look at what happened to two drugs that had 3 syllable names: Oraflex and Loridine.

But then there were two drugs that had 2 syllable names that didn't make it: Ceclor and Axid.

But then there was a drug that had a 4 syllable name that was a big hit: CoPyronil.

But then there was a drug that had a 6 syllable name that was a big hit in the pain relief market: Darvon-N with A.S.A. It was a biggie.

2 syllable names are best.
 












Anonymous said:
But then there were two drugs that had 2 syllable names that didn't make it: Ceclor and Axid.

Excuse me, Ceclor didn't make it? Ceclor funded the research that got us Prozac and Zyprexa. Sales were over $750M back when that was considered a blockbuster. And you think Co-Pyronil was a success? You must be an old Dista rep!! HaHaHa!!
Click to expand...
 






Anonymous said:
Anonymous said:
But then there were two drugs that had 2 syllable names that didn't make it: Ceclor and Axid.

Excuse me, Ceclor didn't make it? Ceclor funded the research that got us Prozac and Zyprexa. Sales were over $750M back when that was considered a blockbuster. And you think Co-Pyronil was a success? You must be an old Dista rep!! HaHaHa!!
Click to expand...

Oh jeez Dista? Lilly? There is so much better available out there, invented in other countries, no regulations in the US, nice safety profiles, wonderful price.

Welcome to the Internet. Your corporate logo, spin, "humanitarian" appearance, etc., are all worthless. Return to a science-based approach and maybe you will survive. However, your workforce has brain damage in the hypothalamus region to repeated unnecessary stress.

Karma is a bitch.
Click to expand...
 












But, but, but,......... Lorabid was "The Right Choice!"

But, but, but,...... Lorabid was the "first Carbacephem!"

But, but, but,....... Lorabid was "a step beyond!"

How could it not have been a big success with the prescribers?

Ceclor and Axid might have produced some dollars for Lilly, but they were drugs that totaly disappeared when the patents ran out. You will never see generic companies lining up to produce generic Ceclor or generic Axid. Probably one of the worst marketing ideas, other than Axid Man, was the Axid CD.
 






























Top Bottom
Back
Quote